Recommended

Discover the latest breakthroughs in environmental monitoring when you download our latest brand report! Get your free copy today!

Explore innovative, purpose-built AI solutions that elevate compliance and efficiency in quality and manufacturing operations.

Explore how lipid formulations in softgels can enhance drug absorption and bioavailability in this upcoming webinar!

Discover approaches to advance manufacturing processes such as continuous manufacturing, address key manufacturing challenges and optimise product quality at our upcoming webinar – Register now!

EPR’s latest Pharma Horizons report explores the latest advances in cell and gene therapy for quality control, manufacturing, analytical development and more – READ MORE

Register for this webinar to learn about impurity control in pharmaceutical waters! Coming soon!

View our brand new Guide to Testing for 2025!

<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-P89LTFL" height="0" width="0" style="display:none;visibility:hidden"></iframe>

List view / Grid view

Novartis

Novartis announces final agreement with Dr. Daniel Vasella

17 July 2013 | By Novartis

The Novartis Board of Directors announced a final agreement with its former Chairman, Dr. Daniel Vasella.

Novartis announces secukinumab (AIN457) demonstrated superiority to Enbrel® in head-to-head Phase III psoriasis study

8 July 2013 | By Novartis

All primary & secondary endpoints were met...

Novartis and Biological E agree to deliver affordable vaccines for typhoid and paratyphoid A fevers to developing world

8 July 2013 | By Novartis

Novartis has entered into a development and licensing agreement with Biological E Limited...

Novartis reports new Phase III data showing omalizumab significantly improves itch in patients with severe form of chronic skin disease CSU[1]

26 June 2013 | By Novartis

Novartis announced late-breaking results...

Sandoz launches Phase III clinical trial for biosimilar etanercept

24 June 2013 | By Novartis

Sandoz has initiated a major Phase III clinical trial with its biosimilar version of etanercept (Amgen's Enbrel®)...

FDA grants breakthrough therapy designation to Novartis’ serelaxin (RLX030) for acute heart failure

21 June 2013 | By Novartis

RLX030 has the potential to address a serious unmet medical need...

Three Scientists to receive prestigious Novartis Prizes for Immunology at 15th International Congress of Immunology

17 June 2013 | By Novartis

The Novartis Prizes for Immunology are awarded to three scientists...

Drug Jakavi® improved overall survival of myelofibrosis patients and impacted an underlying mechanism of disease

16 June 2013 | By Novartis

Results from a Phase III three-year follow-up study...

Switching to Novartis drug Gilenya from standard interferon shown to improve long-term outcomes for patients with MS

10 June 2013 | By Novartis

Two new analyses from the Phase III TRANSFORMS study presented...

New data at ENS show Novartis drug Gilenya benefited patients by improving all four key measures of multiple sclerosis

5 June 2013 | By Novartis

Gilenya improved the key measures...

Novartis breakthrough therapy LDK378 shows a marked clinical response in patients with ALK+ non-small cell lung cancer

3 June 2013 | By Novartis

Novartis announced data on its investigational compound LDK378...

Novartis pivotal Phase III trial shows Afinitor® significantly delays tumor growth in HER2 positive advanced breast cancer

2 June 2013 | By Novartis

Results from a pivotal Phase III trial...

World MS Day: Novartis launches a new campaign to raise awareness of MS

29 May 2013 | By Novartis

Novartis is joining the global multiple sclerosis community in celebration of World MS Day...

Largest-ever global survey of 1,273 women in 12 countries reveals women with advanced breast cancer feel left out of the breast cancer movement

21 May 2013 | By Novartis

New global survey results...

Novartis drug Afinitor® significantly extended time without disease progression in women with HER2 positive advanced breast cancer

17 May 2013 | By Novartis

Results of a pivotal Phase III trial...

© Russell Publishing Limited, 2010-2025. All rights reserved.

Website development by e-Motive Media Limited.

Cookie Settings

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Cookie	Description
cookielawinfo-checkbox-advertising-targeting	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged	This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.

Cookie	Description
cf_ob_info	This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob	This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only	This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush	This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db	This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC	This cookie is set by Youtube and is used to track the views of embedded videos.

Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.

Cookie	Description
bcookie	This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS	This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang	This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc	This cookie is set by LinkedIn and used for routing.
lissc	This cookie is set by LinkedIn share Buttons and ad tags.
vuid	We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId	This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule	This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session	This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues	This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga	This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat	This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid	This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Advertising & Targeting

Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.

Cookie	Description
advanced_ads_browser_width	This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions	This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info	This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer	This cookie is set by Advanced Ads and sets the referrer URL.
bscookie	This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE	This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr	This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory	This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.